Qualification
2557
Pediatric Sarcoma
Baylor College of Medicine
Houston, Texas, USA
2555
อ.ว. กุมารเวชศาสตร์โลหิตวิทยา แพทยสภา
จุฬาลงกรณ์มหาวิทยาลัย
ประเทศไทย
2553
อ.ว. กุมารเวชศาสตร์ แพทยสภา
จุฬาลงกรณ์มหาวิทยาลัย
ประเทศไทย
2547
แพทยศาสตร์บัณฑิต (เกียรตินิยมอันดับ 2)
จุฬาลงกรณ์มหาวิทยาลัย
ประเทศไทย
Selected Publications
2026
Winaichatsak A, Pakakasama S, Anurathapan U, Techavichit P, Poparn H,Sosothikul D, Sathitsamitphong L, Wiwattanakul S, Rujkijyanont P, Puangpetch A.6-Mercaptopurine metabolic profiles and clinical outcomes in TPMT and NUDT15phenotypes during maintenance therapy for Thai paediatric acute lymphoblasticleukaemia. Br J Clin Pharmacol. 2026 Jun 5. doi: 10.1002/bcp.70634. Epub ahead of print. PMID: 42249522. https://doi.org/10.1002/bcp.70634
2026
Amornsillaphachai P, Lertvivatpong N, Sirichotiwat K, Narindrarangkura P,Sinlapamongkolkul P, Pakakasama S, Isaranimitkul D, Techavichit P, Chingnawan S,Sripattanatadasakul P, Sathitsamitphong L, Winaichatsak A, Takpradit C, SudnawaKK, Suwannaying K, Monsereenusorn C. Bridging Gaps in Survivorship Care inLMICs: A Multicenter Study on Healthcare Providers’ Perceptions of Late Effectsin Pediatric Cancer in Thailand. Pediatr Blood Cancer. 2026 Jun;73(6):e70273.doi: 10.1002/1545-5017.70273. Epub 2026 Mar 27. PMID: 41889292. https://doi.org/10.1002/1545-5017.70273
2026
Rujkijyanont P, Ukritchon S, Winaichatsak A, Kuwatjanakul P,Chotsampancharoen T, Techavichit P, Chainansamit SO, Sathitsamitphong L,Kanchanakamhaeng K, Anurathapan U, Laoaroon N, Wangkittikal C, Monsereenusorn C, Sanpote W, Phalakornkul N, Sripattanatadasakul P, Isaranimitkul D, Songkhla PN, Sinlapamongkolkul P, Buaboonnam J, Pakakasama S. Hyperleukocytosis and Access to Minimal Residual Disease Testing Impact Outcomes in Children With Newly Diagnosed Acute Myeloid Leukemia in Thailand. Pediatr Blood Cancer. 2026Mar;73(3):e70004. doi: 10.1002/1545-5017.70004. Epub 2026 Jan 7. PMID: 41496669. https://doi.org/10.1002/1545-5017.70004
2025
Sutthatarn P, Taesombat W, Kruephate M, Sirichindakul P, Nonthasoot B,Achatsachat P, Techavichit P, Phewplung T, Vejchapipat P. Outcomes of major liver resection for children with hepatoblastoma weighing less than 10 kg:avoiding liver transplantation with extended or extreme resection. Pediatr SurgInt. 2025 Nov 27;42(1):29. doi: 10.1007/s00383-025-06249-7. PMID: 41307727. https://doi.org/10.1007/s00383-025-06249-7
2025
Nantavithya C, Prayongrat A, Laohavinij W, Techavichit P, Srilanchakon K,Utoomprurkporn N, Chantadisai M, Wanlapakorn C, Shotelersuk K. Cost-Effectiveness of Proton Versus Photon Therapy for Medulloblastoma Using Updated Clinical Outcomes. Int J Part Ther. 2025 Jun 11;17:100754. doi:10.1016/j.ijpt.2025.100754. PMID: 40678409; PMCID: PMC12269849. https://doi.org/10.1016/j.ijpt.2025.100754
2024
Poparn H, Kittikalayawong Y, Techavichit P, Lauhasurayotin S, Chiengthong K,Chaweephisal P, Sosothikul D. The Incidence and Methods for Detecting Aspirin Resistance in Pediatric Patients. Pediatric Health Med Ther. 2024 Nov 13;15:333-338. doi: 10.2147/PHMT.S478540. PMID: 39559403; PMCID: PMC11571927. https://doi.org/10.2147/PHMT.S478540
2024
Monsereenusorn C, Techavichit P, Sathitsamitphong L, Lertvivatpong N,Winaichatsak A, Chainansamit SO, Buaboonnam J, Kuwatjanakul P, Chotsampancharoen T, Wangkittikal C, Kanchanakamhaeng K, Suwannaying K, Sripattanatadasakul P, Wongruangsri S, Phalakornkul N, Lertkovit O, Sinlapamongkolkul P, Songkhla PN, Prasertphol K, Pakakasama S; Thai Pediatric Oncology Acute Lymphoblastic Leukemia Working Group. Enhancing outcomes of childhood acute lymphoblasticleukemia in workplace diversity in Thailand: multicenter study on behalf of theThai Pediatric Oncology Group. Ann Hematol. 2024 Dec;103(12):5461-5472. doi:10.1007/s00277-024-06068-1. Epub 2024 Nov 5. PMID: 39499298. https://doi.org/10.1007/s00277-024-06068-1
2024
Thangpong R, Nuwongsri P, Ittiwut C, Ittiwut R, Phokaew C, Techavichit P,Suphapeetiporn K. Whole exome sequencing in relapsed or refractory childhoodcancer: case series. Asian Biomed (Res Rev News). 2024 Sep 20;18(4):186-191. doi: 10.2478/abm-2024-0025. PMID: 39309469; PMCID: PMC11414774. https://doi.org/10.2478/abm-2024-0025
2024
Monsereenusorn C, Suwannaying K, Buaboonnam J, Sathitsamitphong L,Techavichit P, Pakakasama S, Chainansamit SO, Anurathapan U, Komvilaisak P,Traivaree C, Sanpakit K, Charoenkwan P, Seksarn P. Nationwide Study of Factors Impacting Survival Outcome and Consequences in Children with Reactivation/Refractory Langerhans Cell Histiocytosis. Asian Pac J Cancer Prev.2024 May 1;25(5):1831-1839. doi: 10.31557/APJCP.2024.25.5.1831. PMID: 38809656; PMCID: PMC11318807. https://doi.org/10.31557/APJCP.2024.25.5.1831
2024
Pinto EM, Fridman C, Figueiredo BC, Salvador H, Teixeira MR, Pinto C,Pinheiro M, Kratz CP, Lavarino C, Legal EAMF, Le A, Kelly G, Koeppe E, StoffelEM, Breen K, Hahner S, Heinze B, Techavichit P, Krause A, Ogata T, Fujisawa Y, Walsh MF, Rana HQ, Maxwell KN, Garber JE, Rodriguez-Galindo C, Ribeiro RC,Zambetti GP. Multiple TP53 p.R337H haplotypes and implications for tumorsusceptibility. HGG Adv. 2024 Jan 11;5(1):100244. doi:10.1016/j.xhgg.2023.100244. Epub 2023 Oct 4. PMID: 37794678; PMCID: PMC10597792. https://doi.org/10.1016/j.xhgg.2023.100244
